Evidence map›Paper›PMID 35992377›Full record

ArticleCurrent research in pharmacology and drug discovery2022

Pir Mohammad Ishfaq, Shivani Mishra, Anjali Mishra, Zaved Ahmad, Shovanlal Gayen, Subodh Kumar Jain, Swati Tripathi, Siddhartha Kumar Mishra

Open access · goldAbstract read
In one paragraph

Article in Current research in pharmacology and drug discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Pir Mohammad IshfaqCancer Biology Laboratory, Department of Zoology, School of Biological Sciences, Dr. Harisingh Gour Central University, Sagar, 470003, (M.P.), India.
Shivani MishraCancer Biology Laboratory, Department of Zoology, School of Biological Sciences, Dr. Harisingh Gour Central University, Sagar, 470003, (M.P.), India.
Anjali MishraCancer Biology Laboratory, Department of Zoology, School of Biological Sciences, Dr. Harisingh Gour Central University, Sagar, 470003, (M.P.), India.
Zaved AhmadCancer Biology Laboratory, Department of Zoology, School of Biological Sciences, Dr. Harisingh Gour Central University, Sagar, 470003, (M.P.), India.
Shovanlal GayenDepartment of Pharmaceutical Sciences, Dr. Harisingh Gour Central University, Sagar, 470003, (M.P.), India.
Subodh Kumar JainMolecular Biology Laboratory, Department of Zoology, School of Biological Sciences, Dr. Harisingh Gour Central University, Sagar, 470003, (M.P.), India.
Swati TripathiAmity Institute of Microbial Technology, Amity University, Noida, 201313, (U.P.), India.
Siddhartha Kumar MishraCancer Biology Laboratory, Department of Zoology, School of Biological Sciences, Dr. Harisingh Gour Central University, Sagar, 470003, (M.P.), India.
University of Lucknow · INDr. Hari Singh Gour University · INAmity University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental toxicants like microcystins are known to adversely impact liver physiology and lead to the increased risk for abnormal liver function and even liver carcinoma. Chaga mushroom (

Indexed as

AntiinflammationApoptosisChaga mushroomHepatotoxicityMicrocystin-LR

Identifiers

PMID35992377
PMCPMC9389225
OpenAlexW4284895876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.